| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |